Meta-analysis of 7 RCTs, 4 cRWE studies, and 2 matched sRWE studies evaluating progression-free survival (PFS) as a surrogate endpoint to overall survival (OS) in metastatic colorectal cancer (mCRC), comparing antiangiogenic treatments with chemotherapy.
A dataframe with 13 rows and 6 columns. Each row represents study results, the columns are:
Author and year.
randomized clinical trial or comparative/single-arm real-world-evidence
logarithm of hazard ratios of progression-free survival
standard error of pfs
logarithm of hazard ratios of overall survival
standard error of os